Autoimmune Responses in the Rheumatoid Synovium by Toes, Rene E. M & Huizinga, Tom W. J
PLoS Medicine  |  www.plosmedicine.org 0015 January 2009  |  Volume 6  |  Issue 1  |  e1000009
Perspective
R
heumatoid arthritis (RA) is a 
chronic inflammatory disorder 
affecting joints, often with 
severe and disabling consequences. 
Although cells and intracellular signals 
characterizing inflamed tissue in RA 
are not qualitatively different from 
those found in other conditions, in 
about one third of patients with RA 
ectopic lymphoid structures can be 
found in affected tissue [1]. These 
structures, which form in response 
to sustained local inflammation, 
reflect the anatomical organization 
through which lymph nodes regulate 
the initiation and maturation 
of productive adaptive immune 
responses. Ectopic lymphoid structures 
therefore appear potentially capable 
of similarly mediating the encounter 
and interaction of immune cells with 
antigens.
Ectopic Lymphoid Structures and 
Autoantibodies
It has long been speculated that ectopic 
lymphoid structures are not only 
generated in response to inflammation, 
but might also contribute to 
inflammation itself by supporting 
the formation and perpetuation of 
pathogenic immune responses [2]. 
Anti-citrullinated protein/peptide 
antibodies (ACPAs) are antibodies 
that recognize post-translationally 
modified proteins in which arginine 
residues have been modified into 
citrulline [3,4]. These antibodies are 
highly specific for RA, directed against 
antigens that are also expressed in 
the inflamed joint and can sometimes 
be detected up to ten years before 
disease development [5,6]. Because 
of these features, combined with 
the observations that their presence 
predicts clinical outcome in RA, and 
that their infusion exacerbates arthritis 
in animals, it is thought that ACPAs 
contribute to RA pathogenesis [7–9]. It 
has also been shown that synovial tissue 
can harbor cells that produce ACPAs 
[10,11].
In a new study published in PLoS
Medicine [12], Costantino Pitzalis and 
co-workers therefore investigated 
whether ectopic lymphoid structures 
present in the inflamed synovium of 
patients with RA actively contribute to 
ongoing B cell responses and whether 
they are involved in the production of 
ACPAs [10]. 
Study Results
The authors analyzed the presence of 
follicular dendritic cells (FDCs) as a 
measure of the presence and extent of 
ectopic lymphoid structures. In lymph 
nodes, FDCs make intimate contact 
with B cells and play a key role in 
selecting antigen-binding B cells during 
the development of antibody responses. 
The authors observed that the presence 
of FDCs was strictly correlated with 
the expression of activation-induced 
cytidine deaminase (AID), an enzyme 
involved in antibody-isotype switching 
and affinity maturation, two processes 
crucial to the development of B cell 
antibody responses. Likewise, AID 
expression was correlated with 
markers implicated in the formation 
of lymphoid structures. Interestingly, 
cellular aggregates containing FDCs 
and expressing AID were found to 
be surrounded with cells recognizing 
citrullinated proteins but not control 
proteins, indicating the presence of 
ACPA-producing B cells. Together, 
these results indicate that the cellular 
aggregates associated with FDCs 
are functional and suggest that they 
contribute to the production of ACPAs. 
Next the authors transplanted 
pieces of inflamed synovium from 
a series of joint biopsies in patients 
with RA into immunodeficient mice 
and followed the maintenance of 
germinal center–like structures in vivo 
as well as the survival and function 
of autoantibody-producing B cells. 
These experiments further confirmed 
the presence of active and self-
sustained lymphoneogenesis within 
the inflamed synovium of patients 
with RA. In mice as in ex vivo human 
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Linked Research Article
This Perspective discusses the 
following new study published in PLoS
Medicine:
Humby F, Bombardieri M, Manzo 
A, Kelly S, Blades MC, et al. (2009) 
Ectopic lymphoid structures support 
ongoing production of class-switched 
autoantibodies in rheumatoid synovium. 
PLoS Med 6(1): e1. doi:10.1371/journal.
pmed.0060001
Costantino Pitzalis and colleagues 
show that lymphoid structures in synovial 
tissue of patients with rheumatoid 
arthritis support production of anti-
citrullinated peptide antibodies, which 
continues following transplantation into 
SCID mice.PLoS Medicine  |  www.plosmedicine.org 0016 January 2009  |  Volume 6  |  Issue 1  |  e1000009
specimens, these ectopic lymphoid 
structures were associated with ongoing 
B cell responses as measured by the 
expression of AID and the presence 
of DNA recombination products that 
are only produced by B cells during 
antibody-isotype switching. ACPAs in 
serum were also detected, but only 
in those mice that were transplanted 
with synovial tissue that contained 
AID-positive cells and thus allowed for 
an ongoing B cell response possibly 
involving ACPA-isotype switching and 
affinity maturation.
Strengths, Limitations, and Next 
Steps
The data presented by Pitzalis and 
co-workers show that B cells that are 
associated with ectopic lymphoid 
structures express the molecular 
machinery required for antibody-
isotype switching and affinity 
maturation. Likewise, they indicate 
that these ectopic lymphoid structures 
could act as a functional tertiary 
lymphoid organ capable of producing 
isotype-switched autoantibodies. 
These observations are in line with 
the evidence suggesting that new B 
cells are continuously recruited into 
the ACPA response and indicate that 
the inflamed synovium is facilitating 
and contributing to a perpetual re-
activation of the RA-specific ACPA 
response during the course of ACPA-
positive arthritis [13].
Nonetheless, the data presented 
do not provide definitive proof that 
ectopic lymphoid structures in RA 
synovium support the production 
of ACPAs. The authors demonstrate 
a clear and convincing association 
between the presence of ectopic 
structures, AID-positive cells in synovial 
tissue, and production of ACPAs 
by synovial tissue, indicating that 
the ectopic structures and/or AID-
positive cells produce or support the 
production of ACPAs. Nonetheless, it is 
not shown that disrupting the ectopic 
structures inhibits the formation of 
ACPAs. Moreover, a recent study 
has indicated that synovial lymphoid 
neogenesis is not correlated with the 
level of autoantibodies in RA patients, 
suggesting that ectopic lymphoid 
structures contribute little to the ACPA 
levels measured in serum or synovial 
fluid [14]. Therefore, it is important 
to delineate the pathogenic impact of 
ectopic lymphoid structures and the 
contribution of lymphoid neogenesis 
to the overall ACPA response in future 
studies. This could be achieved by 
disruption of the ectopic lymphoid 
structures and/or inhibition of 
lymphoneogenesis by targeting 
molecules regulating this process using 
the elegant mouse model developed by 
the authors, which closely recapitulates 
several of the hallmarks taking place in 
humans.
Implications
The new data presented by Pitzalis 
and colleagues indicate that 
lymphoneogenesis in the inflamed 
synovial tissue of patients with RA 
is fostering potentially pathogenic 
immune responses by assisting the 
local production of ACPAs. This could 
promote local inflammation, leading 
to a vicious circle in which more 
lymphogenic factors are produced, 
allowing a further perpetuation of 
the autoimmune responses that drive 
the ongoing disease process [9]. 
Overall, the data presented increase 
our understanding of the relevance 
and functional consequences of the 
microanatomical immunological 
units present in a substantial number 
of patients with RA and provide a 
rationale to target these units as a new 
treatment modality for RA.  
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